Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22446832)

  • 1. Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer.
    Gao Q; Yang S; Kang MQ
    Mol Med Rep; 2012 Jun; 5(6):1409-14. PubMed ID: 22446832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis.
    Xu P; Xu XL; Huang Q; Zhang ZH; Zhang YB
    Med Oncol; 2012 Sep; 29(3):1643-7. PubMed ID: 21874565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Upregulation of survivin in non-small cell lung cancer and its clinicopathological correlation with p53 and Bcl-2].
    Han PH; Li XJ; Qin H; Yao J; DU N; Ren H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):710-3. PubMed ID: 19664395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and clinical significance of apoptosis-related oncogenes in stage I-II non-small cell lung cancer].
    Wang DF; Zeng CG; Lin YB; Hou JH; Zhu ZH
    Ai Zheng; 2006 Mar; 25(3):359-62. PubMed ID: 16536995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases.
    Kren L; Brazdil J; Hermanova M; Goncharuk VN; Kallakury BV; Kaur P; Ross JS
    Appl Immunohistochem Mol Morphol; 2004 Mar; 12(1):44-9. PubMed ID: 15163019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Microvessel density and expressions of survivin and vascular endothelial growth factor in non-small cell lung cancer and their correlations to clinicopathologic features].
    Wang L; Li X; Li Y; Xue YW
    Ai Zheng; 2005 Jul; 24(7):823-6. PubMed ID: 16004808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiple marker analysis of apoptosis-associated protein expression in non-small cell lung cancer in a Chinese population.
    Fan CF; Xu HT; Lin XY; Yu JH; Wang EH
    Folia Histochem Cytobiol; 2011; 49(2):231-9. PubMed ID: 21744322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Elf-1 and survivin in non-small cell lung cancer and their relationship to intratumoral microvessel density.
    Yang DX; Li NE; Ma Y; Han YC; Shi Y
    Chin J Cancer; 2010 Apr; 29(4):396-402. PubMed ID: 20346215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subcellular localization of survivin in non-small cell lung cancer].
    He L; Hou M; Zhang J; Xu N; Chen P
    Ai Zheng; 2009 Sep; 28(9):955-60. PubMed ID: 19728914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin expression impacts prognostically on NSCLC but not SCLC.
    Rosato A; Menin C; Boldrin D; Dalla Santa S; Bonaldi L; Scaini MC; Del Bianco P; Zardo D; Fassan M; Cappellesso R; Fassina A
    Lung Cancer; 2013 Feb; 79(2):180-6. PubMed ID: 23218791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression levels of survivin, Bcl-2, and KAI1 proteins in cervical cancer and their correlation with metastasis.
    Zhou XL; Wang M
    Genet Mol Res; 2015 Dec; 14(4):17059-67. PubMed ID: 26681053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin expression in non-small-cell lung carcinomas: correlation with apoptosis and other apoptosis-related proteins, clinicopathologic prognostic factors and prognosis.
    Ulukus EC; Kargi HA; Sis B; Lebe B; Oztop I; Akkoclu A; Onen A; Sanli A
    Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):31-7. PubMed ID: 17536304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.
    Cho HJ; Kim HR; Park YS; Kim YH; Kim DK; Park SI
    Surg Oncol; 2015 Dec; 24(4):329-34. PubMed ID: 26690822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of survivin and proliferating cell nuclear antigen in human non-small cell lung cancer].
    Zhou JM; Zhou JH; Deng ZH; Zheng H; Jiang HY; Cao HQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):544-8. PubMed ID: 16320585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis.
    Li J; Li ZN; Yu LC; Shi SB; Ge LP; Wu JR; Hu YM
    Clin Transl Oncol; 2013 Nov; 15(11):882-8. PubMed ID: 23404657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis.
    Chen P; Zhu J; Liu DY; Li HY; Xu N; Hou M
    Med Oncol; 2014 Jan; 31(1):775. PubMed ID: 24338338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].
    Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.
    Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK
    Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.